Lucid Diagnostics signals imminent Medicare coverage for EsoGuard while strengthening commercial payer engagement
Source: SeekingAlpha
2025-11-12 14:42:28 ET
More on Lucid Diagnostics
- Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript
- Lucid Diagnostics: Holding Onto Medicare Coverage Hopes
- Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)
- Lucid Diagnostics dips after pricing $25M stock offering
- Lucid Diagnostics announces proposed public offering of common stock
Read the full article on Seeking Alpha
For further details see:
Lucid Diagnostics signals imminent Medicare coverage for EsoGuard while strengthening commercial payer engagement
Lucid Diagnostics Inc.
NASDAQ: LUCD
LUCD Trading
-1.07% G/L:
$1.385 Last:
147,261 Volume:
$1.41 Open:
LUCD Latest News
March 12, 2026 09:01:00 am
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
February 04, 2026 08:01:00 am
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
January 21, 2026 08:00:00 am
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
LUCD Stock Data
$166,596,432
87,428,706
0.61%
29
N/A
Medical Equipment & Supplies
Healthcare
US
New York
